Amylyx Pharmaceuticals, Inc. logo AMLX - Amylyx Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $31.50 DETAILS
HIGH: $40.00
LOW: $24.00
MEDIAN: $31.00
CONSENSUS: $31.50
DOWNSIDE: 10.28%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Stable Earnings Power

AlphaQuality — archetype-weighted quantitative grade

F 29.7 / 100 pillar composite

Composite Grade

Composite of six pillars weighted for stable earnings power businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 29.7 pillar composite because hard gates always win. Use the pillar breakdown below to see where the underlying numbers sit.

Profitability

Weight: 20%
D- 30.0
  • 5yr Avg ROIC -52.6% 0/100
  • Operating Margin Trend +272.75 pp/yr 100/100
Contributes 6.0 pts toward composite.

Capital Efficiency

Weight: 15%
F 0.0
  • 5yr Avg ROE -69.4% 0/100
  • 5yr Share-Count CAGR 10.9% 0/100
Contributes 0.0 pts toward composite.

Growth Quality

Weight: 15%
F 20.0
  • Revenue-Growth Years (5) 1/5 20/100
Contributes 3.0 pts toward composite.

Cash Generation

Weight: 15%
F 9.8
  • 5yr FCF Margin -336.6% 0/100
  • 5yr FCF/NI Conversion 0.22x 22/100
Contributes 1.5 pts toward composite.

Balance Sheet

Weight: 20%
C 55.0
  • Net Debt / EBITDA 10.00x 0/100
  • Interest Coverage (EBIT/Int) 30.00x 100/100
  • Altman Z-Score 82.02 100/100
Contributes 11.0 pts toward composite.

Stability

Weight: 15%
C 54.5
  • Negative-Revenue Years (5) 1/5 80/100
  • Piotroski F-Score 3 33/100
Contributes 8.2 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed.

Holders
2
Avg Δ position
+21.0%
New buys
0
Full exits
0
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (20%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (15%) — Revenue-Growth Years (5)
  • Cash Generation (15%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (20%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (15%) — Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.